Hot Features
プレミアム
Solid Biosciences Inc (SLDB)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-02 | Mr. Ian F. SmithExecutive Chair | 3.44k | 0.00 | Derivative Exercise and Retained Stock | - | 134.71k | 2.62% |
| 2026-03-11 | RA Capital Management, L.P.法人 | 3.16M | 23.71M | 買い | 7.28 - 7.79 | 8.83M | 55.61% |
| 2026-02-06 | RA Capital Management, L.P.法人 | 354.94k | 2.30M | 買い | 6.49 | 5.67M | 6.67% |
| 2026-02-13 | Mr. Alexander G. CumboPresident, CEO & Director | 13.39k | 0.00 | Derivative Exercise and Retained Stock | - | 235.41k | 6.03% |
| 2026-02-13 | Mr. Alexander G. CumboPresident, CEO & Director | -16.64k | 96.92k | Derivative Exercise and Sale | 5.82 | 235.41k | - |
| 2026-02-13 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | 3.99k | 0.00 | Derivative Exercise and Retained Stock | - | 74.32k | 5.67% |
| 2026-02-13 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | -4.13k | 24.07k | Derivative Exercise and Sale | 5.82 | 74.32k | - |
| 2026-02-13 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | 2.20k | 0.00 | Derivative Exercise and Retained Stock | - | 146.17k | 1.53% |
| 2026-02-13 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | -2.66k | 15.48k | Derivative Exercise and Sale | 5.82 | 146.17k | - |
| 2026-02-13 | Mr. Paul HerzichCTO | 3.57k | 0.00 | Derivative Exercise and Retained Stock | - | 72.64k | 5.17% |
| 2026-02-13 | Mr. Paul HerzichCTO | -3.62k | 21.06k | Derivative Exercise and Sale | 5.82 | 72.64k | - |
| 2026-02-13 | Mr. David Tyronne HowtonCOO & Secretary | 7.22k | 0.00 | Derivative Exercise and Retained Stock | - | 105.08k | 7.38% |
| 2026-02-13 | Mr. David Tyronne HowtonCOO & Secretary | -7.47k | 43.49k | Derivative Exercise and Sale | 5.82 | 105.08k | - |
| 2026-02-13 | Dr. Gabriel BrooksChief Medical Officer | 5.37k | 0.00 | Derivative Exercise and Retained Stock | - | 89.47k | 6.39% |
| 2026-02-13 | Dr. Gabriel BrooksChief Medical Officer | -5.56k | 32.40k | Derivative Exercise and Sale | 5.82 | 89.47k | - |
| 2026-02-13 | Mr. Kevin TanCFO & Treasurer | 5.22k | 0.00 | Derivative Exercise and Retained Stock | - | 99.42k | 5.54% |
| 2026-02-13 | Mr. Kevin TanCFO & Treasurer | -5.40k | 31.47k | Derivative Exercise and Sale | 5.82 | 99.42k | - |
| 2026-02-04 | Mr. David Tyronne HowtonCOO & Secretary | -18.89k | 121.71k | 売り | 6.44 | 97.86k | -16.18% |
| 2026-02-04 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | -7.21k | 46.41k | 売り | 6.44 | 143.96k | -4.77% |
| 2026-02-04 | Mr. Alexander G. CumboPresident, CEO & Director | -48.91k | 315.09k | 売り | 6.44 | 222.02k | -18.05% |
| 2026-02-04 | Mr. Kevin TanCFO & Treasurer | -14.78k | 95.23k | 売り | 6.44 | 94.20k | -13.56% |
| 2026-02-04 | Dr. Gabriel BrooksChief Medical Officer | -12.62k | 81.27k | 売り | 6.44 | 84.09k | -13.05% |
| 2026-02-04 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | -12.35k | 79.54k | 売り | 6.44 | 70.33k | -14.94% |
| 2026-02-04 | Mr. Paul HerzichCTO | -10.91k | 70.25k | 売り | 6.44 | 69.07k | -13.64% |
| 2026-01-29 | Mr. Kevin TanCFO & Treasurer | 62.88k | 0.00 | Derivative Exercise and Retained Stock | - | 108.98k | 136.41% |
| 2026-01-31 | Mr. Kevin TanCFO & Treasurer | -26.84k | 172.75k | Derivative Exercise and Sale | 6.44 | 108.98k | - |
| 2026-01-29 | Mr. Alexander G. CumboPresident, CEO & Director | 189.54k | 0.00 | Derivative Exercise and Retained Stock | - | 270.93k | 232.89% |
| 2026-01-31 | Mr. Alexander G. CumboPresident, CEO & Director | -80.26k | 516.61k | Derivative Exercise and Sale | 6.44 | 270.93k | - |
| 2026-01-29 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | 56.02k | 0.00 | Derivative Exercise and Retained Stock | - | 82.68k | 210.11% |
| 2026-01-31 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | -26.54k | 170.80k | Derivative Exercise and Sale | 6.44 | 82.68k | - |
| 2026-01-29 | Dr. Gabriel BrooksChief Medical Officer | 58.74k | 0.00 | Derivative Exercise and Retained Stock | - | 96.71k | 154.69% |
| 2026-01-29 | Dr. Gabriel BrooksChief Medical Officer | -28.34k | 182.39k | Derivative Exercise and Sale | 6.44 | 96.71k | - |
| 2026-01-29 | Mr. David Tyronne HowtonCOO & Secretary | 83.85k | 0.00 | Derivative Exercise and Retained Stock | - | 116.75k | 254.79% |
| 2026-01-31 | Mr. David Tyronne HowtonCOO & Secretary | -37.77k | 243.13k | Derivative Exercise and Sale | 6.44 | 116.75k | - |
| 2026-01-29 | Mr. Paul HerzichCTO | 53.35k | 0.00 | Derivative Exercise and Retained Stock | - | 79.97k | 200.40% |
| 2026-01-29 | Mr. Paul HerzichCTO | -26.25k | 168.97k | Derivative Exercise and Sale | 6.44 | 79.97k | - |
| 2026-01-31 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | 15.00k | 0.00 | Derivative Exercise and Retained Stock | - | 151.17k | 11.02% |
| 2026-01-27 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | 4.08k | 0.00 | Derivative Exercise and Retained Stock | - | 136.17k | 3.09% |
| 2026-01-27 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | -191.00 | 1.26k | Derivative Exercise and Sale | 6.59 | 136.17k | - |
| 2026-01-09 | Mr. Kevin TanCFO & Treasurer | 5.55k | 0.00 | Derivative Exercise and Retained Stock | - | 46.10k | 13.68% |
| 2026-01-09 | Mr. Kevin TanCFO & Treasurer | -5.70k | 30.06k | Derivative Exercise and Sale | 5.27 | 46.10k | - |
| 2026-01-06 | Mr. Ian F. SmithExecutive Chair | 4.57k | 0.00 | Derivative Exercise and Retained Stock | - | 131.26k | 3.61% |
| 2026-01-03 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | 1.94k | 0.00 | Derivative Exercise and Retained Stock | - | 132.09k | 1.49% |
| 2026-01-03 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | -1.05k | 5.72k | Derivative Exercise and Sale | 5.43 | 132.09k | - |
| 2025-12-02 | Mr. David Tyronne HowtonCOO & Secretary | 8.12k | 0.00 | Derivative Exercise and Retained Stock | - | 32.91k | 32.75% |
| 2025-12-02 | Mr. David Tyronne HowtonCOO & Secretary | -4.93k | 25.20k | Derivative Exercise and Sale | 5.11 | 32.91k | - |
| 2025-12-02 | Mr. Alexander G. CumboPresident, CEO & Director | 17.80k | 0.00 | Derivative Exercise and Retained Stock | - | 81.39k | 28.00% |
| 2025-12-02 | Mr. Alexander G. CumboPresident, CEO & Director | -10.81k | 55.23k | Derivative Exercise and Sale | 5.11 | 81.39k | - |
| 2025-12-02 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | 7.38k | 0.00 | Derivative Exercise and Retained Stock | - | 26.66k | 38.27% |
| 2025-12-02 | Dr. Jessie HanrahanChief Regulatory & Preclinical Operations Officer | -4.48k | 22.91k | Derivative Exercise and Sale | 5.11 | 26.66k | - |
| 2025-12-02 | Mr. Paul HerzichCTO | 4.54k | 0.00 | Derivative Exercise and Retained Stock | - | 26.62k | 20.55% |
| 2025-12-02 | Mr. Paul HerzichCTO | -2.70k | 13.80k | Derivative Exercise and Sale | 5.11 | 26.62k | - |
| 2025-11-10 | Mr. Ilan GanotCo-founder, Strategic Advisor to the CEO & Director | -3.28k | 13.51k | 売り | 4.12 | 129.65k | -2.47% |
| 2025-10-18 | Dr. Gabriel BrooksChief Medical Officer | 6.86k | 0.00 | Derivative Exercise and Retained Stock | - | 33.82k | 25.42% |
| 2025-10-18 | Dr. Gabriel BrooksChief Medical Officer | -2.90k | 17.25k | Derivative Exercise and Sale | 5.96 | 33.82k | - |
| 2025-10-06 | Mr. Ian F. SmithExecutive Chair | 4.57k | 0.00 | Derivative Exercise and Retained Stock | - | 126.69k | 3.74% |
| 2025-06-16 | RA Capital Management, L.P.法人 | 553.04k | 2.48M | 買い | 4.31 - 4.50 | 5.67M | 10.80% |
| 2025-07-06 | Mr. Ian F. SmithExecutive Chair | 4.57k | 0.00 | Derivative Exercise and Retained Stock | - | 122.12k | 3.89% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
